Screener
Mirum Pharmaceuticals, Inc. MIRM Accrued contract manufacturing and non-clinical costs
Accrued contract manufacturing and non-clinical costs at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:AccruedContractManufacturingAndNonClinicalCostsCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accrued compensation and related benefits | 28,389 | 47,276 |
| Accrued clinical trials | 22,872 | 13,959 |
| Accrued professional service fees | 21,886 | 17,292 |
| Accrued contract manufacturing and non-clinical costs | 17,670 | 8,721 |
| Accrued royalties payable | 16,204 | 16,208 |
| Operating lease liabilities, current | 2,405 | 2,139 |
| Accrued loss on firm purchase commitments | 2,107 | 2,107 |
| Accrued interest | 527 | 2,108 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accrued contract manufacturing and non-clinical costs of $17.67M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs increased by 170.2% year-over-year, from $6.54M to $17.67M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs has grown at a -6.2% compound annual growth rate (CAGR), from $9.92M to $8.72M.
- What does accrued contract manufacturing and non-clinical costs mean?
- Accrued contract manufacturing and non-clinical costs as reported by Mirum Pharmaceuticals, Inc. Common Stock.
Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude